This is well in line with other published data showing that SNORA42 is commonly increased in a number of solid tumors including lung cancer and that high SNORA42 expression in NSCLC patients correlated with poor survival [36]. This evidence concerns the gene SNORA80E and non-small cell lung carcinoma.